If you made any changes in Pure these will be visible here soon.

Personal profile


I became a lecturer in pharmaceutical sciences in the Aston School of Pharmacy in 1999. Prior to that I had undertaken postdoctoral research in synthetic chemistry at Bonn and Aston as well as nearly six years working for a contract research company. My research interests have broadened out from synthetic chemistry to include molecular modelling and drug design. The current focus is on the design and synthesis of antimicrobial compounds, tissue transglutaminase inhibitors and the application of computational methods to pharmaceutical formulations.

Research Interests

  • Design, synthesis and screening of libraries of new antimycobacterial compounds
  • Computer aided drug design
  • Molecular recognition in fluorescent imprinted polymers and their use as sensors and receptor mimics
  • Design and synthesis of transglutaminase inhibitors

Teaching Activity

Aston Pharmacy School MPharm course: Chemical aspects of pharmacy.

Various MSc courses: Drug design and drug discovery.

Undergraduate biology and biochemistry  courses: Chemistry for biology


PhD (Chemistry, Warwick University, 1987)

BA (Chemistry, St Edmund Hall, Oxford University)

Contact Details

Telephone: +44 (0) 121 204 4002

Room: MB357D

Email: D.L.Rathbone@aston.ac.uk


  • QD Chemistry
  • Molecular modelling
  • Drug design
  • Antimicrobial compounds
  • Transglutaminase inhibitors
  • Chemical synthesis

Fingerprint Dive into the research topics where Dan Rathbone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Open Access
  • Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus

    Lopeman, R. C., Harrison, J., Rathbone, D., Desai, M., Lambert, P. & Cox, J. A. G., 27 Jan 2020, In : Scientific Reports. 10, 1, 928.

    Research output: Contribution to journalArticle

    Open Access
  • Design, Stability and Efficacy of a New Targeting Peptide for Nanoparticulate Drug Delivery to SH-SY5Y Neuroblastoma Cells

    Huey, R., Rathbone, D., McCarron, P. & Hawthorne, S., 21 Oct 2019, In : Journal of Drug Targeting. 27, 9, p. 959-970 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • Reaction profiling of a set of acrylamide-based human tissue transglutaminase inhibitors

    Jasim, M. & Rathbone, D. L., 1 Jan 2018, In : Journal of Molecular Graphics and Modelling . 79, p. 157-165 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • Development of potent and selective tissue transglutaminase inhibitors: their effect on TG2 function and application in pathological conditions

    Badarau, E., Wang, Z., Rathbone, D. L., Costanzi, A., Thibault, T., Murdoch, C. E., El Alaoui, S., Bartkeviciute, M. & Griffin, M., 22 Oct 2015, In : Chemistry and Biology. 22, 10, p. 1347-1361 15 p.

    Research output: Contribution to journalArticle

    Open Access